Dideoxycytidine toxicity on mouse hemopoietic progenitors

Area of Science:

• Pharmacology
• Toxicology
• Hematology

Background:

• Antiviral compounds can exhibit toxicity.
• 2', 3' Dideoxycytidine (ddc) is a potent antiviral in vitro.
• ddc is under investigation for AIDS and related conditions.

Purpose of the Study:

• To assess the toxicity of 2', 3' Dideoxycytidine (ddc) on hemopoietic progenitor cells.
• To evaluate the potential clinical significance of ddc toxicity.

Main Methods:

• Studied the effects of ddc on mouse hemopoietic progenitors.
• Assessed the in vitro antiviral activity of ddc against human T cell lymphotropic viruses.

Main Results:

• ddc demonstrated toxic activity against mouse hemopoietic progenitors.
• ddc is highly potent in vitro against human T cell lymphotropic viruses.

Conclusions:

• ddc exhibits toxicity towards hemopoietic progenitor cells.
• Further research is needed to determine the clinical relevance of ddc toxicity in patients.